
Virusine infekcija užsikrečiama įkvepiant oru plintančius lašelius su virusais po to, kai sergantis žmogus nusičiaudėjo arba nusikosėjo (vieno nusičiaudėjimo metu į orą patenka ~100 000 virusų), tiesioginio artimo kontakto su sergančiu žmogumi metu bei rankomis palietus užkrėstus paviršius, o po to – savo nosį, akis ar burną. VKTI (peršalimo) gydymo ir profilaktikos naujienos
Literatūra:
1. Efficacy and safety of an antiviral Iota-Carrageenan nasal spray: a randomized, double-blind, placebo-controlled exploratory study in volunteers with early symptoms of the common cold. Eccles R. et al. Respiratory Research 2010, 11:108.
2. Lessons learned from a double-blind randomised placebo-controlled study with a iota-carrageenan nasal spray as medical device in children with acute symptoms of common cold . Fazekas T. et al. BMC Complementary and Alternative Medicine 2012, 12:147.
3. Efficacy of a Carrageenan nasal spray in patients with common cold: a randomized controlled trial. Ludwig et al. Respiratory Research 2013 14:124.
4. Carrageenan nasal spray in virus confirmed common cold: individual patient data analysis of two randomized controlled trials. Koenighofer et al. Multidisciplinary Respiratory Medicine 2014 9:57.
5. Iota-Carrageenan is a potent inhibitor of rhinovirus infection. Grassauer et al. Virology Journal 2008, 5:107.
6. Iota-Carrageenan Is a Potent Inhibitor of Influenza A Virus Infection. Leibbrandt et al. PLOS ONE 2010, 5:12.
7. BMJ Best Practice review for Common Cold (http://bestpractice.bmj.com)